Back to search

Article

Therapy-related acute lymphoblastic leukaemia has a unique genetic profile compared to de novo acute lymphoblastic leukaemia

2022-04-14

Abstract excerpt

Unlike therapy-related myeloid neoplasms, therapy-related acute lymphoblastic leukaemia (t-ALL) is poorly defined due to its rarity. However, increasing reports have demonstrated that t-ALL is a distinct entity with adverse genetic features and clinical outcomes. We compared the clinicopathological characteristics and outcomes of patients diagnosed with t-ALL ( n = 9) or de novo ALL (dn-ALL; n = 162) at a single i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c377c2e7-6d05-5ebf-b66a-ff592816ddb5
DOI
10.21203/rs.3.rs-1535649/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapy-related acute lymphoblastic leukaemia has a unique genetic profile compared to de novo acute lymphoblastic leukaemiaDOI 10.21203/rs.3.rs-1535649/v1
Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic LeukaemiaSemantic proximity
T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatmentsSemantic proximity
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.Semantic proximity
Clinical Relevance and Applicability of the 2022 World Health Organization Classification of Childhood B Lymphoblastic Leukemia in the Context of MRD-Directed TherapySemantic proximity
Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odyssey.Semantic proximity
Genomic heterogeneity contributed to different prognosis between adult and pediatric acute lymphoblastic.Semantic proximity
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.Semantic proximity
Clinical Relevance and Applicability of the 2022 World Health Organization Classification of Childhood B Lymphoblastic Leukemia in the Context of MRD-Directed TherapySemantic proximity
Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.Semantic proximity
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.Semantic proximity
Novel Biomarkers and Molecular Targets in ALL.Semantic proximity
The genomic landscape of pediatric acute lymphoblastic leukemia.Semantic proximity
Select a neighboring publication to make it the new centre.